190 related articles for article (PubMed ID: 10741734)
1. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Skrk J
Neoplasma; 2001; 48(1):66-71. PubMed ID: 11327540
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
4. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.
Smid L; Strojan P; Budihna M; Skrk J; Vrhovec I; Zargi M; Kos J
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S150-3. PubMed ID: 9065652
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
[TBL] [Abstract][Full Text] [Related]
7. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.
Kos J; Smid A; Krasovec M; Svetic B; Lenarcic B; Vrhovec I; Skrk J; Turk V
Biol Chem Hoppe Seyler; 1995 Jul; 376(7):401-5. PubMed ID: 7576236
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic profile of cysteine proteases and inhibitors determines tumor cell phenotype in squamous cell carcinoma of the head and neck.
Strojan P; Aničin A; Svetic B; Šmid L; Kos J
Int J Biol Markers; 2011; 26(4):247-54. PubMed ID: 22139645
[TBL] [Abstract][Full Text] [Related]
11. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.
Strojan P; Oblak I; Svetic B; Smid L; Kos J
Br J Cancer; 2004 May; 90(10):1961-8. PubMed ID: 15138478
[TBL] [Abstract][Full Text] [Related]
12. Cystatins and cathepsins in breast carcinoma.
Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
[TBL] [Abstract][Full Text] [Related]
13. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
14. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.
Harbeck N; Alt U; Berger U; Kates R; Krüger A; Thomssen C; Jänicke F; Graeff H; Schmitt M
Int J Biol Markers; 2000; 15(1):79-83. PubMed ID: 10763146
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cathepsins B and L in primary human breast cancer.
Foekens JA; Kos J; Peters HA; Krasovec M; Look MP; Cimerman N; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
J Clin Oncol; 1998 Mar; 16(3):1013-21. PubMed ID: 9508185
[TBL] [Abstract][Full Text] [Related]
17. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
Cimerman N; Mesko Brguljan P; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 2001 Aug; 310(2):113-22. PubMed ID: 11498076
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins B and L are markers for clinically invasive types of meningiomas.
Strojnik T; Zidanik B; Kos J; Lah TT
Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer.
Castiglioni T; Merino MJ; Elsner B; Lah TT; Sloane BF; Emmert-Buck MR
Hum Pathol; 1994 Sep; 25(9):857-62. PubMed ID: 8088759
[TBL] [Abstract][Full Text] [Related]
20. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma.
Lah TT; Kokalj-Kunovar M; Strukelj B; Pungercar J; Barlic-Maganja D; Drobnic-Kosorok M; Kastelic L; Babnik J; Golouh R; Turk V
Int J Cancer; 1992 Jan; 50(1):36-44. PubMed ID: 1728611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
